vs

Side-by-side financial comparison of James River Group Holdings, Inc. (JRVR) and TANDEM DIABETES CARE INC (TNDM). Click either name above to swap in a different company.

TANDEM DIABETES CARE INC is the larger business by last-quarter revenue ($247.2M vs $151.4M, roughly 1.6× James River Group Holdings, Inc.). On growth, TANDEM DIABETES CARE INC posted the faster year-over-year revenue change (5.5% vs -12.1%). Over the past eight quarters, TANDEM DIABETES CARE INC's revenue compounded faster (5.5% CAGR vs -10.3%).

James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

JRVR vs TNDM — Head-to-Head

Bigger by revenue
TNDM
TNDM
1.6× larger
TNDM
$247.2M
$151.4M
JRVR
Growing faster (revenue YoY)
TNDM
TNDM
+17.6% gap
TNDM
5.5%
-12.1%
JRVR
Faster 2-yr revenue CAGR
TNDM
TNDM
Annualised
TNDM
5.5%
-10.3%
JRVR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
JRVR
JRVR
TNDM
TNDM
Revenue
$151.4M
$247.2M
Net Profit
$-20.4M
Gross Margin
55.3%
Operating Margin
37.6%
Net Margin
-8.2%
Revenue YoY
-12.1%
5.5%
Net Profit YoY
EPS (diluted)
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JRVR
JRVR
TNDM
TNDM
Q1 26
$151.4M
$247.2M
Q4 25
$167.7M
$290.4M
Q3 25
$172.7M
$249.3M
Q2 25
$174.8M
$240.7M
Q1 25
$172.3M
$234.4M
Q4 24
$126.7M
$282.6M
Q3 24
$191.5M
$244.0M
Q2 24
$188.3M
$221.9M
Net Profit
JRVR
JRVR
TNDM
TNDM
Q1 26
$-20.4M
Q4 25
$32.1M
$-589.0K
Q3 25
$1.0M
$-21.2M
Q2 25
$4.8M
$-52.4M
Q1 25
$9.6M
$-130.6M
Q4 24
$-64.8M
$755.0K
Q3 24
$-39.4M
$-23.3M
Q2 24
$7.6M
$-30.8M
Gross Margin
JRVR
JRVR
TNDM
TNDM
Q1 26
55.3%
Q4 25
57.7%
Q3 25
53.9%
Q2 25
52.3%
Q1 25
50.5%
Q4 24
55.7%
Q3 24
51.1%
Q2 24
50.8%
Operating Margin
JRVR
JRVR
TNDM
TNDM
Q1 26
37.6%
Q4 25
14.6%
2.9%
Q3 25
1.5%
-9.2%
Q2 25
4.2%
-21.5%
Q1 25
9.3%
-51.6%
Q4 24
-57.0%
-0.2%
Q3 24
-27.1%
-10.7%
Q2 24
10.7%
-13.9%
Net Margin
JRVR
JRVR
TNDM
TNDM
Q1 26
-8.2%
Q4 25
19.1%
-0.2%
Q3 25
0.6%
-8.5%
Q2 25
2.7%
-21.8%
Q1 25
5.6%
-55.7%
Q4 24
-51.1%
0.3%
Q3 24
-20.6%
-9.5%
Q2 24
4.0%
-13.9%
EPS (diluted)
JRVR
JRVR
TNDM
TNDM
Q1 26
$-0.30
Q4 25
$0.59
$0.02
Q3 25
$-0.02
$-0.31
Q2 25
$0.06
$-0.78
Q1 25
$0.16
$-1.97
Q4 24
$-2.44
$0.00
Q3 24
$-1.10
$-0.35
Q2 24
$0.13
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JRVR
JRVR
TNDM
TNDM
Cash + ST InvestmentsLiquidity on hand
$228.2M
$570.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$518.4M
$132.4M
Total Assets
$4.8B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JRVR
JRVR
TNDM
TNDM
Q1 26
$228.2M
$570.3M
Q4 25
$260.9M
$292.7M
Q3 25
$238.8M
$319.1M
Q2 25
$220.0M
$315.4M
Q1 25
$279.4M
$368.6M
Q4 24
$362.3M
$438.3M
Q3 24
$359.8M
$473.3M
Q2 24
$672.5M
$452.4M
Stockholders' Equity
JRVR
JRVR
TNDM
TNDM
Q1 26
$518.4M
$132.4M
Q4 25
$538.2M
$155.2M
Q3 25
$503.6M
$133.0M
Q2 25
$492.6M
$133.3M
Q1 25
$484.5M
$155.3M
Q4 24
$460.9M
$263.1M
Q3 24
$530.3M
$237.7M
Q2 24
$541.8M
$233.9M
Total Assets
JRVR
JRVR
TNDM
TNDM
Q1 26
$4.8B
$1.2B
Q4 25
$4.9B
$881.1M
Q3 25
$5.0B
$874.7M
Q2 25
$5.0B
$875.7M
Q1 25
$4.9B
$922.1M
Q4 24
$5.0B
$967.7M
Q3 24
$5.0B
$957.7M
Q2 24
$4.7B
$937.5M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons